Pleins feux sur les glucides et la nutrition

2010 | 2009 | 2008 | 2007 | 2006 | Années precedents

ABSTRACT

Richard Kahn, PHD¹, John Buse, MD, PHD², Ele Ferrannini, MD³ and Michael Stern, MD⁴
(¹ American Diabetes Association, Alexandria, Virginia; ² Division of Endocrinology and of General Medicine & Clinical Epidemiology, University of North Carolina School of Medicine, Chapel Hill, North Carolina; ³ Department of Internal Medicine, University of Pisa School of Medicine, Pisa, Italy; ⁴ Division of Clinical Epidemiology, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas)
Diabetes Care 2005, September; 28:2289-2304

The term "metabolic syndrome" refers to a clustering of specific cardiovascular disease (CVD) risk factors whose underlying pathophysiology is thought to be related to insulin resistance. Since the term is widely used in research and clinical practice, we undertook an extensive review of the literature in relation to the syndrome’s definition, underlying pathogenesis, and association with CVD and to the goals and impact of treatment. While there is no question that certain CVD risk factors are prone to cluster, we found that the metabolic syndrome has been imprecisely defined, there is a lack of certainty regarding its pathogenesis, and there is considerable doubt regarding its value as a CVD risk marker. Our analysis indicates that too much critically important information is missing to warrant its designation as a "syndrome." Until much needed research is completed, clinicians should evaluate and treat all CVD risk factors without regard to whether a patient meets the criteria for diagnosis of the "metabolic syndrome."

haut de la page »

© Institut canadien du sucre
10 rue Bay, bureau 620 - Toronto, Ontario, M5J 2R8
Tél: 416-368-8091 - Téléc: 416-368-6426 | info@sugar.ca | www.sugar.ca |